Your browser doesn't support javascript.
loading
Integrative pan-cancer analysis of MEK1 aberrations and the potential clinical implications.
Zhou, Zhiyang; Peng, Bi; Li, Juanni; Gao, Kewa; Cai, Yuan; Xu, Zhijie; Yan, Yuanliang.
Affiliation
  • Zhou Z; Department of Breast Surgery, Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Peng B; Department of Pathology, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, China.
  • Li J; Department of Pathology, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, China.
  • Gao K; Department of Pathology, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, China.
  • Cai Y; Department of Pathology, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, China.
  • Xu Z; Department of Pathology, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, China.
  • Yan Y; Department of Pharmacy, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, China. yanyuanliang@csu.edu.cn.
Sci Rep ; 11(1): 18366, 2021 09 15.
Article in En | MEDLINE | ID: mdl-34526571

Full text: 1 Database: MEDLINE Main subject: MAP Kinase Kinase 1 / Mutation / Neoplasms Limits: Humans Language: En Journal: Sci Rep Year: 2021 Type: Article Affiliation country: China

Full text: 1 Database: MEDLINE Main subject: MAP Kinase Kinase 1 / Mutation / Neoplasms Limits: Humans Language: En Journal: Sci Rep Year: 2021 Type: Article Affiliation country: China